Coloplast A/S (OTCMKTS:CLPBY) Announces Quarterly Earnings Results, Meets Estimates

Coloplast A/S (OTCMKTS:CLPBY) issued its earnings results on Tuesday. The company reported $0.10 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.10, Zacks reports. Coloplast A/S had a net margin of 7.46% and a return on equity of 33.15%.

Coloplast A/S Stock Down 1.5%

CLPBY opened at $6.58 on Tuesday. Coloplast A/S has a fifty-two week low of $5.64 and a fifty-two week high of $10.03. The company has a debt-to-equity ratio of 1.66, a quick ratio of 1.09 and a current ratio of 1.75. The company has a market capitalization of $14.83 billion, a P/E ratio of 47.00, a P/E/G ratio of 2.12 and a beta of 0.13. The stock has a fifty day moving average of $6.23 and a 200-day moving average of $6.68.

Wall Street Analyst Weigh In

Separately, Kepler Capital Markets raised shares of Coloplast A/S to a “strong-buy” rating in a research report on Wednesday, May 20th. One equities research analyst has rated the stock with a Strong Buy rating, one has issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, Coloplast A/S currently has a consensus rating of “Hold”.

About Coloplast A/S

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.